-
Vincristine Sulfate: Assay Workflows & Optimization
2026-09-25
Build more interpretable cancer research assays by connecting vincristine’s microtubule mechanism to dose selection, exposure timing, and orthogonal readouts. This workflow distinguishes product-backed benchmarks from experiment-specific starting conditions—and flags where a cited inflammation review should not be mistaken for evidence about vincristine.
-
DiscoveryProbe Stem Cell Compound Library Plus: Screening
2026-09-25
Pair a 280-compound pathway-focused collection with imaging and orthogonal assays to distinguish stem cell phenotypes that simple viability or morphology readouts can miss. A Schistosoma mansoni study demonstrates how stem-cell-focused screening can also inform parasite drug discovery—with important limits when translating across models.
-
DMG-PEG2000-NH2 for Lipid Delivery Workflows
2026-09-24
DMG-PEG2000-NH2 combines a lipid-associated PEG structure with a reactive primary amine, making it useful for exploratory conjugation and lipid-formulation workflows. This guide distinguishes those applications from siRNA encapsulation itself and offers practical starting conditions, controls, and troubleshooting steps without overstating what the tuberculosis reference study demonstrates.
-
(-)-Arctigenin in Macrophage–Breast Cancer Signaling
2026-09-24
Macrophage-derived extracellular vesicles can carry miR-660 into breast cancer cells, weakening KLHL21 restraint of IKKβ/NF-κB signaling. This article maps where (-)-Arctigenin may serve as a mechanistic probe—and how to test that possibility without confusing pathway activity with proof of therapeutic relevance.
-
ORM2–ZG16 Signaling Limits Pancreatic Fibrosis
2026-09-23
A 2026 study reports that ORM2 reduces pancreatic fibrosis in chronic pancreatitis by binding ZG16 and limiting autophagy-driven activation of pancreatic stellate cells. Its combination of mouse models, stellate-cell experiments, and autophagy-flux assays identifies a candidate regulatory pathway while leaving important questions about human relevance and therapeutic translation open.
-
Veratridine Workflows for Sodium Channel Assays
2026-09-23
Veratridine provides a controllable way to sustain sodium-channel activation in excitotoxicity models, blocker screens, and mechanistic neurobiology. This workflow-focused guide connects its voltage-gated sodium channel activity with practical assay design, reference-backed timing, and troubleshooting for reproducible results.
-
Pregnancy, LNP Structure, and mRNA Delivery
2026-09-22
This PNAS study demonstrates that lipid nanoparticle structure and administration route jointly determine mRNA potency, inflammatory responses, and maternal–fetal outcomes during pregnancy. Its findings provide a mechanistic framework for designing safer pregnancy-focused RNA delivery systems and for interpreting reporter-expression data in related mRNA workflows.
-
Bone Transport and TGF-β1 in Diabetic Foot Ulcers
2026-09-22
A 2026 rat study identifies TGF-β1/TGFBR1 activation as a mechanistic link between bone transport, angiogenesis, immune regulation, and diabetic foot ulcer repair. Its design supports a pathway-level interpretation while also defining important limits for translating wound-healing findings into fibrosis or renal research.
-
Nelfinavir Mesylate in HIV and Ferroptosis
2026-09-21
Nelfinavir Mesylate combines a well-defined HIV-1 protease mechanism with an emerging use in DDI2–NFE2L1 and ferroptosis research. This guide translates its pharmacology into practical antiviral, proteostasis, and cell-death workflows with formulation, assay-design, and troubleshooting advice.
-
Licoricidin and PI3K/AKT Signaling in HCC
2026-09-21
A 2026 study investigated licoricidin, a prenylated isoflavone from Glycyrrhiza uralensis, as an inhibitor of hepatocellular carcinoma growth and metastasis. Using complementary cellular and animal models, the researchers associated its activity with apoptosis, S-phase arrest, epithelial–mesenchymal transition suppression, and reduced PI3K/AKT signaling.
-
Berbamine hydrochloride: NF-κB Activity Inhibitor
2026-09-19
Berbamine hydrochloride is a versatile pharmacological probe for connecting STAT3, calcium homeostasis, NF-κB signaling, and ferroptosis-related phenotypes. This workflow translates the METTL16-SENP3-LTF findings in hepatocellular carcinoma into practical dose-response, pathway, iron, and lipid-peroxidation assays.
-
B. fragilis, Vagal Cholinergic Signaling, and Seizures
2026-09-18
Jia et al. identify a gut–vagus–brain cholinergic circuit through which oral Bacteroides fragilis suppresses seizures in mice and shows efficacy in a randomized trial of pediatric refractory epilepsy. The study links colonic ChAT-positive cells, vagal transmission, and Lactobacillus colonization, providing a mechanistic framework for microbiota-targeted seizure research.
-
Human iPSC Intestinal Organoids for Pharmacokinetics
2026-09-18
Saito and colleagues developed a direct three-dimensional culture strategy for generating expandable intestinal organoids from human induced pluripotent stem cells. The organoids could be cryopreserved, expanded, and converted into two-dimensional intestinal epithelial monolayers containing metabolically and transport-competent enterocytes, creating a practical human model for oral drug pharmacokinetic studies.
-
Oligo (dT) 25 Beads for Immune-Cell RNA Workflows
2026-09-17
Oligo (dT) 25 Beads provide a selective, magnet-assisted route from total RNA or eukaryotic cells to polyadenylated mRNA for cDNA, RT-PCR, and sequencing workflows. This practical guide connects immune-aging research with sample-preparation decisions, including bead handling, direct cDNA synthesis, quality control, and troubleshooting.
-
NSC-23766: A Rac1 Assay Decision Framework
2026-09-17
NSC-23766 is a Rac GTPase inhibitor that links Rac1-GEF biology to interpretable cancer and cell-signaling assays. This evidence-based guide explains how to distinguish target engagement from downstream toxicity, using breast cancer combination data to improve experimental decisions.